Company: Sun Pharmaceutical Industries Ltd. Category: IPO Notes


NULL
May 29, 2019, 10:45 a.m.
Publisher: moneycontrol.com

NULL
Feb. 13, 2019, 11:04 a.m.
Publisher: moneycontrol.com

Global brokerage firms have a target price in the range of Rs 535-560 on Sun Pharma which translates into an upside of 22-28 percent return in the next 12 months.
Feb. 13, 2019, 10:32 a.m.
Publisher: moneycontrol.com

Emkay and Motilal Oswal see 17 percent year-on-year growth in bottomline while Prabhudas Lilladher expects profit to grow 137 percent and ICICI Securities expects 178 percent
Feb. 12, 2019, 11:06 a.m.
Publisher: moneycontrol.com


Ranvir Singh of Systematix Shares joins in and gives his view on which way one should be looking at Sun Pharma Listen in!
Dec. 6, 2018, midnight
Publisher: youtube.com

Operational performance shows improvement, with EBITDA rising 11 percent.
Nov. 13, 2018, 4:08 p.m.
Publisher: moneycontrol.com

Brokerages expect profit to be around Rs 950-1,087 crore.
Nov. 13, 2018, 9:30 a.m.
Publisher: moneycontrol.com

Net Sales are expected to increase by 12.5 percent Y-o-Y (up 3.6 percent Q-o-Q) to Rs. 7,480 crore, according to HDFC Securities.
Oct. 17, 2018, 5:35 p.m.
Publisher: moneycontrol.com

Net Sales are expected to increase by 13.7 percent Y-o-Y (up 4.7 percent Q-o-Q) to Rs. 7,560 crore, according to Sharekhan.
Oct. 16, 2018, 7:16 p.m.
Publisher: moneycontrol.com

Net Sales are expected to increase by 15.8 percent Y-o-Y (up 6.6 percent Q-o-Q) to Rs. 7,698.1 crore, according to ICICI Direct.
Oct. 12, 2018, 5:41 p.m.
Publisher: moneycontrol.com

-->